Zurowska, Aleksandra https://orcid.org/0000-0002-3354-5344
Drozynska-Duklas, Magdalena https://orcid.org/0000-0002-1792-1776
Topaloglu, Rezan https://orcid.org/0000-0002-6423-0927
Bouts, Antonia https://orcid.org/0000-0002-4121-6698
Boyer, Olivia https://orcid.org/0000-0002-3957-1359
Shenoy, Mohan https://orcid.org/0000-0002-2456-3006
Vivarelli, Marina https://orcid.org/0000-0002-2448-1959
,
Alpay, H.
Andersen, R.
Ariceta, G.
Atmış, B.
Bayrakçı, U. S.
Esrea, B.
Baudouin, V.
Bervina, N.
Benetti, E.
Berard, E.
Bjerre, A.
Christian, M.
Couderc, A.
Dehoorne, J.
Deschenes, G.
Dossier, C.
Düşünsel, R.
Ekinci, Z.
Emma, F.
Espinoza, L.
Gianviti, A.
Herrero Goñi, M.
Guido, G.
Ghio, L.
Groothoff, J.
Hacıhamdioğlu, D. Ö.
Espino Hernández, M.
Jankauskiene, A.
Kagan, M.
Kemper, M.
Kovacevic, M.
Kohl, S.
Kramar, R. T.
López-González, M.
Aris, A. M.
Maringhini, S.
Marlais, M.
Melgosa, M.
Mitsioni, A.
Montini, G.
Moczulska, A.
Murer, L.
Obukhova, V.
Oh, J.
Ortega, P.
Özçakar, Z. B.
Ulinski, T.
Pasini, A.
Papalia, T.
Paunova, S.
Pena, A.
Pecoraro, C.
Petrosyan, E.
Peruzzi, L.
Printza, N.
Prikhodina, L.
Pietrement, C.
Rittig, S.
Rodrigo, D.
Savenkova, N.
Saraga, M.
Sever, F. L.
Schreuder, M.
Szczepanska, M.
Tasic, V.
Tonshoff, B.
Tullus, K.
Vara, J.
Vande Walle, J.
Volokhina, E.
Zieg, J.
Waters, A.
Weber, L. T.
Webbe, N.
Wasiak, M.
Article History
Received: 5 October 2022
Revised: 13 January 2023
Accepted: 8 February 2023
First Online: 4 April 2023
Change Date: 9 December 2024
Change Type: Update
Change Details: The original online HTML version of this article was revised: The individual authors listed only in the acknowledgments were incorrectly included in the author line as collaborators representing the ESPN Glomerulonephritis Working Group.
Change Date: 19 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00467-024-06625-w
Declarations
:
: 1. Marina Vivarelli declared potential conflict of interests:- Grants – Alexion- Sponsored clinical trials – Chinook, Novartis, Bayer, Rche, Apellis, Travere, Alexion, Chemocentrix- Lectures – Travere, Alexion, WebMD- Consultancy fees – Novartis, Biocryst, Roche- Advisory board – Novartis2. Aleksandra Zurowska declared potential conflict of interests: lectures for Swixx BioPharma3. Mohan Shenoy declared potential conflict of interests: advisory board – Novartis4. Olivia Boyer declared potential conflict of interests: consultancy fees – Rocher5. Magdalena Drozynska-Duklas – no conflict of interests to disclose